实用医学杂志
實用醫學雜誌
실용의학잡지
THE JOURNAL OF PRACTICAL MEDICINE
2014年
17期
2709-2711
,共3页
祝剑虹%王汉东%樊友武%孙青%纪祥军%刘寰东%周梦良
祝劍虹%王漢東%樊友武%孫青%紀祥軍%劉寰東%週夢良
축검홍%왕한동%번우무%손청%기상군%류환동%주몽량
胶质瘤干细胞%Nrf2%胶质母细胞瘤
膠質瘤榦細胞%Nrf2%膠質母細胞瘤
효질류간세포%Nrf2%효질모세포류
Glioma stem cell%Nrf2%Glioblastoma
目的:研究胶质瘤干细胞中 Nrf2的表达变化及其入核表达情况,寻找胶质瘤干细胞治疗的新靶点。方法:分别用 Western 和 qPCR 从蛋白和 RNA 转录两个层次比较胶质母细胞瘤细胞系以及胶质瘤干细胞的 Nrf2表达的差异,使用免疫荧光染色初步探讨 Nrf2的活化入核情况。结果: U87和 U251裸鼠种植瘤中胶质瘤干细胞的比例分别为1.24%和1.63%。胶质瘤干细胞中的 Nrf2含量高于胶质瘤细胞系,mRNA 含量也存在相同的差异。免疫荧光显示胶质瘤干细胞中入核的 Nrf2较高。结论:Nrf2信号通路是胶质瘤干细胞功能的潜在调控因子。
目的:研究膠質瘤榦細胞中 Nrf2的錶達變化及其入覈錶達情況,尋找膠質瘤榦細胞治療的新靶點。方法:分彆用 Western 和 qPCR 從蛋白和 RNA 轉錄兩箇層次比較膠質母細胞瘤細胞繫以及膠質瘤榦細胞的 Nrf2錶達的差異,使用免疫熒光染色初步探討 Nrf2的活化入覈情況。結果: U87和 U251裸鼠種植瘤中膠質瘤榦細胞的比例分彆為1.24%和1.63%。膠質瘤榦細胞中的 Nrf2含量高于膠質瘤細胞繫,mRNA 含量也存在相同的差異。免疫熒光顯示膠質瘤榦細胞中入覈的 Nrf2較高。結論:Nrf2信號通路是膠質瘤榦細胞功能的潛在調控因子。
목적:연구효질류간세포중 Nrf2적표체변화급기입핵표체정황,심조효질류간세포치료적신파점。방법:분별용 Western 화 qPCR 종단백화 RNA 전록량개층차비교효질모세포류세포계이급효질류간세포적 Nrf2표체적차이,사용면역형광염색초보탐토 Nrf2적활화입핵정황。결과: U87화 U251라서충식류중효질류간세포적비례분별위1.24%화1.63%。효질류간세포중적 Nrf2함량고우효질류세포계,mRNA 함량야존재상동적차이。면역형광현시효질류간세포중입핵적 Nrf2교고。결론:Nrf2신호통로시효질류간세포공능적잠재조공인자。
Objective To compare different Nrf2 expressions in glioblastoma cell lines and glioma stem cells (GSCs) from xenografts and to study the concentration of Nrf2 in nuclear. Methods GSCs were analyzed by immunofluorescence and different expressions of Nrf2 in glioblastoma cell lines and GSCs from xenografts were detected with real-time RCR and Western. Results GSCs were successfully isolated from xenografts of U251 and U87 cell lines. The percentage of tumor stem cells in total cells was 1.24%, and that was 1.63% in xenografts. Immunofluorescence indicated that Nrf2 was overexpressed in GSCs as compared with that in glioblastoma cell lines. Conclusion Nrf2 may be a potential biomarker and rational therapeutic target for GSCs.